SBC Medical | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 43.06 M

Revenue: As of FY2026 Q1, the actual value is USD 43.06 M, beating the estimate of USD 41.66 M.

EPS: As of FY2026 Q1, the actual value is USD 0.11, beating the estimate of USD 0.1.

EBIT: As of FY2026 Q1, the actual value is USD 17.71 M.

Financial Highlights for the Three Months Ended March 31, 2026

• Total Revenues, net: Total revenues, net, were $43,060,562, representing a 9% year-over-year decrease .
• Net Income Attributable to SBC Medical Group Holdings Incorporated: Net income attributable to SBC Medical Group Holdings Incorporated was $11,308,071, representing a 47% year-over-year decrease .
• Net Income Margin: The net income margin was 26% for the first quarter of 2026, a year-over-year decrease of 19 percentage points .
• EBITDA: EBITDA was $18,390,449, representing a 26% year-over-year decrease .
• EBITDA Margin: The EBITDA margin was 43% for the first quarter of 2026, a year-over-year decrease of 10 percentage points .
• Return on Equity: Return on Equity was 18%, representing a year-over-year decrease of 23 percentage points .

Operational Metrics for the Three Months Ended March 31, 2026

• Number of Franchise Locations: The number of franchise locations was 284 as of March 31, 2026, an increase of 33 locations from March 31, 2025 .
• Number of Customers: The company served 6.76 million customers in the last twelve months ended March 31, 2026, a 10% year-over-year increase .
• Repeat Rate for Customers: The repeat rate for customers who visited franchisee’s clinics twice or more was 72% .

Income Statement Highlights for the Three Months Ended March 31, 2026

• Gross Profit: Gross profit was $30,346,734, compared to $37,733,084 for the three months ended March 31, 2025 .
• Operating Expenses: Operating expenses were $12,626,719, compared to $13,531,010 for the three months ended March 31, 2025 .
• Income from Operations: Income from operations was $17,720,015, compared to $24,202,074 for the three months ended March 31, 2025 .
• Income Tax Expense: Income tax expense was $7,527,591, compared to $9,959,457 for the three months ended March 31, 2025 .
• Net Income: Net income was $11,329,020, compared to $21,491,950 for the three months ended March 31, 2025 .

Cash Flow Highlights for the Three Months Ended March 31, 2026

• Net Cash Provided by Operating Activities: Net cash provided by operating activities was $9,231,938, compared to $1,928,621 for the three months ended March 31, 2025 .
• Net Cash Used in Investing Activities: Net cash used in investing activities was - $528,025, compared to - $978,807 for the three months ended March 31, 2025 .
• Net Cash Used in Financing Activities: Net cash used in financing activities was - $1,842,414, compared to - $280,380 for the three months ended March 31, 2025 .
• Cash and Cash Equivalents: Cash and cash equivalents were $167,305,095 as of March 31, 2026, compared to $132,055,823 as of March 31, 2025 .

Balance Sheet Highlights as of March 31, 2026

• Total Assets: Total assets were $388,019,576, up from $380,447,946 as of December 31, 2025 .
• Total Liabilities: Total liabilities were $117,635,399, up from $117,143,240 as of December 31, 2025 .
• Total Stockholders’ Equity: Total stockholders’ equity was $270,384,177, up from $263,304,706 as of December 31, 2025 .

Outlook

SBC Medical Group Holdings Incorporated plans to continue its multi-brand strategy in aesthetic dermatology, expand its non-aesthetic medical business, and strengthen its operational foundation in overseas markets . The company will also pursue opportunities in the longevity market and enhance services through AI utilization, aiming to build a sustainable and continuously growing healthcare platform .